Obesity Research Today is a free monthly online journal that collates and summarizes the latest research about Obesity, including details on health, diet, prevention, exercise.

Volume 2 (2005), Issue 4 (April)

1. Biliopancreatic diversion as a novel approach to the HAIR-AN syndrome.
   Obes Surg, 15(2): 286-9. [Abstract] [Full-text]
2. Topical anesthesia-induced methemoglobinemia in bariatric surgery patients.
   Obes Surg, 15(2): 282-5. [Abstract] [Full-text]
3. Hepatic portal gas due to gastro-jejunal anastomotic leak after laparoscopic gastric bypass.
   Obes Surg, 15(2): 278-81. [Abstract] [Full-text]
4. Response of recurrent binge eating and weight gain to topiramate in patients with binge eating disorder after bariatric surgery.
   Obes Surg, 15(2): 273-7. [Abstract] [Full-text]
5. Exploring the impact of obesity surgery on patients' health status: a quantitative and qualitative study.
   Obes Surg, 15(2): 266-72. [Abstract] [Full-text]
6. Compliance with surgical after-care following bariatric surgery for morbid obesity: a retrospective study.
   Obes Surg, 15(2): 261-5. [Abstract] [Full-text]
7. Efficacy of the SF-36 questionnaire in identifying obese patients with psychological discomfort.
   Obes Surg, 15(2): 254-60. [Abstract] [Full-text]
8. Laparoscopic cholecystectomy in obese patients.
   Obes Surg, 15(2): 243-6. [Abstract] [Full-text]
9. Gallbladder pathology in morbid obesity.
   Obes Surg, 15(2): 238-42. [Abstract] [Full-text]
10. Histological changes in the liver of morbidly obese patients: correlation with metabolic parameters.
    Obes Surg, 15(2): 228-37. [Abstract] [Full-text]
11. Vertical banded gastroplasty: 6 years experience at a center in Poland.
    Obes Surg, 15(2): 223-7. [Abstract] [Full-text]
12. Salvage of gastric restriction following staple-line dehiscence after vertical banded gastroplasty by insertion of an adjustable gastric band.
    Obes Surg, 15(2): 216-22. [Abstract] [Full-text]
13. Critical extreme anterior slippage (paragastric Richter's hernia) of the stomach after laparoscopic adjustable gastric banding: early recognition and prevention of gastric strangulation.
    Obes Surg, 15(2): 207-15; discussion 215. [Abstract] [Full-text]
14. Factors influencing patient choice for bariatric operation.
    Obes Surg, 15(2): 202-6. [Abstract] [Full-text]
15. Weight loss and postoperative complications in morbidly obese patients with binge eating disorder treated by laparoscopic adjustable gastric banding.
    Obes Surg, 15(2): 195-201. [Abstract] [Full-text]
16. Weight changes in spouses of gastric bypass patients.
    Obes Surg, 15(2): 191-4. [Abstract] [Full-text]
17. Fasting plasma ghrelin levels increase progressively after biliopancreatic diversion: one-year follow-up.
    Obes Surg, 15(2): 187-90. [Abstract] [Full-text]
18. Weight loss composition: the effects of exercise following obesity surgery as measured by bioelectrical impedance analysis.
    Obes Surg, 15(2): 183-6. [Abstract] [Full-text]
19. Long-term outcomes after gastric bypass.
    Obes Surg, 15(2): 155-63. [Abstract] [Full-text]
20. Nutritional deficiencies following bariatric surgery: what have we learned?
    Obes Surg, 15(2): 145-54. [Abstract] [Full-text]
21. Netherlands research programme weight gain prevention (NHF-NRG): rationale, objectives and strategies.
    Eur J Clin Nutr, 59(4): 498-507. [Abstract] [Full-text]
22. Obesity is associated with increased risk of allergy in Vietnamese adolescents.
    Eur J Clin Nutr, 59(4): 571-7. [Abstract] [Full-text]
23. Identification of adipocyte adhesion molecule (ACAM), a novel CTX gene family, implicated in adipocyte maturation and development of obesity.
    Biochem J, 387: 343-53. [Abstract] [Full-text]
24. Capella's gastroplasty: metabolites and acute phase proteins changes in midline and bilateral arciform approaches.
    Arq Gastroenterol, 41(4): 215-9. [Abstract] [Full-text]
25. Short- and long-term beneficial effects of a combined dietary-behavioral-physical activity intervention for the treatment of childhood obesity.
    Pediatrics, 115(4): e443-9. [Abstract] [Full-text]
26. The association between glucose challenge test, obesity and pregnancy outcome in 6390 non-diabetic women.
    J Matern Fetal Neonatal Med, 17(1): 29-34. [Abstract] [Full-text]
27. Trp64Arg polymorphism of the beta3-adrenergic receptor gene, pre-pregnancy obesity and risk of pre-eclampsia.
    J Matern Fetal Neonatal Med, 17(1): 19-28. [Abstract] [Full-text]
28. Ethnicity, socio-economic status, overweight and underweight in East London adolescents.
    Ethn Health, 10(2): 113-28. [Abstract] [Full-text]
29. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents.
    Pediatrics, 115(4): e500-3. [Abstract] [Full-text]
30. Anesthesia in the obese patient: pharmacokinetic considerations.
    J Clin Anesth, 17(2): 134-45. [Abstract] [Full-text]
31. Ovarian follicular lipoapoptosis: structural, cytochemical and metabolic basis of reproductive tract atrophy following expression of the hypogonadal diabetes (db/db) syndrome.
    Reprod Toxicol, 20(1): 31-8. [Abstract] [Full-text]
32. Carbohydrate intake is correlated with biomarkers for coronary heart disease in a population of overweight premenopausal women.
    J Nutr Biochem, 16(4): 245-50. [Abstract] [Full-text]
33. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women.
    Clin Endocrinol (Oxf), 62(4): 487-91. [Abstract] [Full-text]
34. A biphasic response of hepatobiliary cholesterol metabolism to dietary fat at the onset of obesity in the mouse.
    Hepatology, 41(4): 887-95. [Abstract] [Full-text]
35. Changing the tide: an Internet/video exercise and low-fat diet intervention with middle-school students.
    Appl Nurs Res, 18(1): 13-21. [Abstract] [Full-text]
36. Racial and etiopathologic dichotomies in insulin hypersecretion and resistance in obese children.
    J Pediatr, 146(4): 474-81. [Abstract] [Full-text]
37. A review of the metabolic effects of sibutramine.
    Curr Med Res Opin, 21(3): 457-68. [Abstract] [Full-text]
38. Low-fat, high-carbohydrate (low-glycaemic index) diet induces weight loss and preserves lean body mass in obese healthy subjects: results of a 24-week study.
    Diabetes Obes Metab, 7(3): 290-3. [Abstract] [Full-text]
39. Comparison of air displacement plethysmograph and bioelectrical impedance for assessing body composition changes during weight loss in Japanese women.
    Diabetes Obes Metab, 7(3): 268-72. [Abstract] [Full-text]
40. Effect of orlistat on cardiovascular disease risk in obese adults.
    Diabetes Obes Metab, 7(3): 254-62. [Abstract] [Full-text]
41. Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients.
    Diabetes Obes Metab, 7(3): 246-53. [Abstract] [Full-text]
42. Diazoxide-mediated insulin suppression in obese men: a dose-response study.
    Diabetes Obes Metab, 7(3): 239-45. [Abstract] [Full-text]
43. Abdominal obesity predicts declining insulin sensitivity in non-obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS).
    Diabetes Obes Metab, 7(3): 230-8. [Abstract] [Full-text]
44. The effect of diets high in protein or carbohydrate on inflammatory markers in overweight subjects.
    Diabetes Obes Metab, 7(3): 223-9. [Abstract] [Full-text]
45. Metabolic risk factors in formerly obese women--effects of a pronounced weight loss by gastric band operation compared with weight loss by diet alone.
    Diabetes Obes Metab, 7(3): 216-22. [Abstract] [Full-text]
46. Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism.
    Diabetes Obes Metab, 7(3): 211-5. [Abstract] [Full-text]
47. Angiopoietin-related growth factor antagonizes obesity and insulin resistance.
    Nat Med, 11(4): 400-8. [Abstract] [Full-text]
48. Changing patterns of under- and over-nutrition in South African children-future risks of non-communicable diseases.
    Ann Trop Paediatr, 25(1): 3-15. [Abstract] [Full-text]
49. Is glutamate decarboxylase 2 (GAD2) a genetic link between low birth weight and subsequent development of obesity in children?
    J Clin Endocrinol Metab, 90(4): 2384-90. [Abstract] [Full-text]
50. Diet-induced weight loss is associated with decreases in plasma serum amyloid a and C-reactive protein independent of dietary macronutrient composition in obese subjects.
    J Clin Endocrinol Metab, 90(4): 2244-9. [Abstract] [Full-text]
51. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents.
    J Clin Endocrinol Metab, 90(4): 2161-8. [Abstract] [Full-text]
52. Suppression of hepatic cholesteryl ester transfer protein expression in obese humans with the development of type 2 diabetes mellitus.
    J Clin Endocrinol Metab, 90(4): 2250-8. [Abstract] [Full-text]
53. The GHRH/GHRP-6 test for the diagnosis of GH deficiency in elderly or severely obese men.
    Eur J Endocrinol, 152(4): 575-80. [Abstract] [Full-text]
54. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome.
    J Intellect Disabil Res, 49: 245-52. [Abstract] [Full-text]
55. Mutation analysis of the preproghrelin gene: no association with obesity and type 2 diabetes.
    Clin Biochem, 38(5): 420-4. [Abstract] [Full-text]
56. A nonimprinted Prader-Willi Syndrome (PWS)-region gene regulates a different chromosomal domain in trans but the imprinted pws loci do not alter genome-wide mRNA levels.
    Genomics, 85(5): 630-40. [Abstract] [Full-text]
57. Prevalence of obesity, binge eating, and night eating in a cross-sectional field survey of 6-year-old children and their parents in a German urban population.
    J Child Psychol Psychiatry, 46(4): 385-93. [Abstract] [Full-text]
58. Effect of a high or low ambient perinatal temperature on adult obesity in Osborne-Mendel and S5B/Pl rats.
    Am J Physiol Regul Integr Comp Physiol, 288(5): R1376-84. [Abstract] [Full-text]
59. Regulation of adiponectin receptor gene expression in diabetic mice.
    Am J Physiol Endocrinol Metab, 288(5): E876-82. [Abstract] [Full-text]
60. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women.
    Arch Intern Med, 165(7): 777-83. [Abstract] [Full-text]
61. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study.
    Arch Intern Med, 165(7): 742-8. [Abstract] [Full-text]
62. Overweight and obesity among Norwegian schoolchildren: changes from 1993 to 2000.
    Scand J Public Health, 33(2): 99-106. [Abstract] [Full-text]
63. Efficacy of sequential or simultaneous interactive computer-tailored interventions for increasing physical activity and decreasing fat intake.
    Ann Behav Med, 29(2): 138-46. [Abstract] [Full-text]
64. Metabolic risk during antipsychotic treatment.
    Clin Ther, 26(12): 1936-46. [Abstract] [Full-text]
65. Endoscopy in the bariatric surgical patient.
    Gastroenterol Clin North Am, 34(1): 151-66. [Abstract] [Full-text]
66. Endoscopic treatments for obesity: past, present and future.
    Gastroenterol Clin North Am, 34(1): 143-50. [Abstract] [Full-text]
67. Surgical options for obesity.
    Gastroenterol Clin North Am, 34(1): 127-42. [Abstract] [Full-text]
68. Gastrointestinal management of the bariatric surgery patient.
    Gastroenterol Clin North Am, 34(1): 105-25. [Abstract] [Full-text]
69. Pharmacological therapies for obesity.
    Gastroenterol Clin North Am, 34(1): 91-104. [Abstract] [Full-text]
70. Diet options of obesity: fad or famous?
    Gastroenterol Clin North Am, 34(1): 83-90. [Abstract] [Full-text]
71. Obesity and disease of the esophagus and colon.
    Gastroenterol Clin North Am, 34(1): 63-82. [Abstract] [Full-text]
72. Hepatic complications of obesity.
    Gastroenterol Clin North Am, 34(1): 45-61. [Abstract] [Full-text]
73. Gastroesophageal reflux disease and obesity.
    Gastroenterol Clin North Am, 34(1): 35-43. [Abstract] [Full-text]
74. Metabolic complications of bariatric surgery: diagnosis and management issues.
    Gastroenterol Clin North Am, 34(1): 25-33. [Abstract] [Full-text]
75. Metabolic implications of obesity: before and after gastric bypass.
    Gastroenterol Clin North Am, 34(1): 9-24. [Abstract] [Full-text]
76. Epidemiology of obesity in the United States.
    Gastroenterol Clin North Am, 34(1): 1-7. [Abstract] [Full-text]
77. Total laparoscopic hysterectomy versus total abdominal hysterectomy for obese women with endometrial cancer.
    Int J Gynecol Cancer, 15(2): 319-24. [Abstract] [Full-text]
78. Proximal femur bone geometry is appropriately adapted to lean mass in overweight children and adolescents.
    Bone, 36(3): 568-76. [Abstract] [Full-text]
79. Sedentary behaviour, physical activity and weight problems in adolescents in Wales.
    Public Health, 119(6): 518-24. [Abstract] [Full-text]
80. Prospective evaluation of folic acid supplementation on plasma homocysteine concentrations during weight reduction: a randomized, double-blinded, placebo-controlled study in obese women.
    Life Sci, 76(18): 2137-45. [Abstract] [Full-text]
81. Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects.
    Obes Surg, 15(3): 387-97. [Abstract] [Full-text]
82. Adiponectin expression and adipose tissue lipolytic activity in lean and obese women.
    Obes Surg, 15(3): 382-6. [Abstract] [Full-text]
83. The effect of surgical weight reduction on functional status in morbidly obese patients with low back pain.
    Obes Surg, 15(3): 378-81. [Abstract] [Full-text]
84. Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity.
    Obes Surg, 15(3): 367-77. [Abstract] [Full-text]
85. Port complications following laparoscopic adjustable gastric banding for morbid obesity.
    Obes Surg, 15(3): 361-5. [Abstract] [Full-text]
86. Continuous positive airway pressure (CPAP) changes in bariatric surgery patients undergoing rapid weight loss.
    Obes Surg, 15(3): 336-41. [Abstract] [Full-text]
87. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Obes Surg, 15(3): 310-5. [Abstract] [Full-text]
88. Fat cells: afferent and efferent messages define new approaches to treat obesity.
    Annu Rev Pharmacol Toxicol, 45: 119-46. [Abstract] [Full-text]
89. Therapy-related changes in body size in Hispanic children with acute lymphoblastic leukemia.
    Cancer, 103(8): 1725-9. [Abstract] [Full-text]
90. Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome.
    Hum Mol Genet, 14(8): 983-95. [Abstract] [Full-text]
91. Application of an algorithm-driven protocol to simultaneously provide universal and targeted prevention programs.
    Int J Eat Disord, 37(3): 220-6. [Abstract] [Full-text]
92. A comparison of quality of life in obese individuals with and without binge eating disorder.
    Int J Eat Disord, 37(3): 234-40. [Abstract] [Full-text]
93. The contribution of childhood and adult socioeconomic position to adult obesity and smoking behaviour: an international comparison.
    Int J Epidemiol, 34(2): 335-44. [Abstract] [Full-text]
94. The Lewis blood group--a new genetic marker of obesity.
    Int J Obes (Lond), 29(5): 540-2. [Abstract] [Full-text]
95. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
    Am J Hypertens, 18(4): 557-65. [Abstract] [Full-text]
96. Circadian blood pressure variation in morbidly obese hypertensive patients undergoing gastric bypass surgery.
    Am J Hypertens, 18(4): 446-51. [Abstract] [Full-text]
97. Family and early life factors associated with changes in overweight status between ages 5 and 14 years: findings from the Mater University Study of Pregnancy and its outcomes.
    Int J Obes (Lond), 29(5): 475-82. [Abstract] [Full-text]
98. Post-treatment phone contact: a weight maintenance strategy in obese youngsters.
    Int J Obes (Lond), 29(5): 543-6. [Abstract] [Full-text]
99. Orlistat in responding obese type 2 diabetic patients: meta-analysis findings and cost-effectiveness as rationales for reimbursement in Sweden and Switzerland.
    Int J Obes (Lond), 29(5): 517-23. [Abstract] [Full-text]
100. TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass.
     Ann Nutr Metab, 49(1): 54-63. [Abstract] [Full-text]
101. Trends in overweight, obesity and central fat accumulation among Tehranian adults between 1998-1999 and 2001-2002: Tehran lipid and glucose study.
     Ann Nutr Metab, 49(1): 3-8. [Abstract] [Full-text]
102. Effect of pronounced weight loss on the nontraditional cardiovascular risk marker matrix metalloproteinase-9 in middle-aged morbidly obese women.
     Int J Obes (Lond), 29(5): 498-501. [Abstract] [Full-text]
103. The relation between drinking pattern and body mass index and waist and hip circumference.
     Int J Obes (Lond), 29(5): 490-7. [Abstract] [Full-text]
104. Long-period accelerometer monitoring shows the role of physical activity in overweight and obesity.
     Int J Obes (Lond), 29(5): 502-8. [Abstract] [Full-text]
105. Indices of whole-body and central adiposity for evaluating the metabolic load of obesity.
     Int J Obes (Lond), 29(5): 483-9. [Abstract] [Full-text]
106. Clinical evidence for drug treatments in obesity-associated hypertensive patients--a discussion paper.
     Methods Find Exp Clin Pharmacol, 27(2): 119-25. [Abstract] [Full-text]
107. Obesity-related cardiovascular risk factors: intervention recommendations to decrease adolescent obesity.
     J Pediatr Nurs, 20(1): 3-14. [Abstract] [Full-text]
108. Fat distribution is strongly associated with plasma glucose levels and diabetes in Thai adults-the InterASIA study.
     Diabetologia, 48(4): 657-60. [Abstract] [Full-text]
109. Laparoscopic Roux-en-Y gastric bypass: results and learning curve of a high-volume academic program.
     Arch Surg, 140(4): 362-7. [Abstract] [Full-text]
110. Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 years.
     Clin Cancer Res, 11(8): 2883-8. [Abstract] [Full-text]
111. Prevalence of the metabolic syndrome and overweight among adults in China.
     Lancet, 365(9468): 1398-405. [Abstract] [Full-text]
112. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.
     Lancet, 365(9468): 1389-97. [Abstract] [Full-text]
113. Stearoyl-CoA desaturase as a new drug target for obesity treatment.
     Obes Rev, 6(2): 169-74. [Abstract] [Full-text]
114. Does weight loss prognosis depend on genetic make-up?
     Obes Rev, 6(2): 155-68. [Abstract] [Full-text]
115. Rapid growth in infancy and childhood and obesity in later life--a systematic review.
     Obes Rev, 6(2): 143-54. [Abstract] [Full-text]
116. Obesity: the protein leverage hypothesis.
     Obes Rev, 6(2): 133-42. [Abstract] [Full-text]
117. Comparison of overweight and obesity prevalence in school-aged youth from 34 countries and their relationships with physical activity and dietary patterns.
     Obes Rev, 6(2): 123-32. [Abstract] [Full-text]
118. Prevalence of obesity in Korea.
     Obes Rev, 6(2): 117-21. [Abstract] [Full-text]
119. Prevalence of obesity in Israel.
     Obes Rev, 6(2): 115-6. [Abstract] [Full-text]
120. Prevalence of obesity in Poland.
     Obes Rev, 6(2): 113-4. [Abstract] [Full-text]
121. Adverse events of herbal food supplements for body weight reduction: systematic review.
     Obes Rev, 6(2): 93-111. [Abstract] [Full-text]
122. Effects of weight status on the recommendations of and adherence to lifestyle modifications among hypertensive adults.
     J Hum Hypertens, 19(5): 365-71. [Abstract] [Full-text]
123. Association analysis of the Gln223Arg polymorphism in the human leptin receptor gene, and traits related to obesity in Mexican adolescents.
     J Hum Hypertens, 19(5): 341-6. [Abstract] [Full-text]
124. Secular trends in cardiovascular disease risk factors according to body mass index in US adults.
     JAMA, 293(15): 1868-74. [Abstract] [Full-text]
125. Excess deaths associated with underweight, overweight, and obesity.
     JAMA, 293(15): 1861-7. [Abstract] [Full-text]
126. Values in the care for young persons with Prader-Willi syndrome: creating a meaningful life together.
     Child Care Health Dev, 31(3): 309-19. [Abstract] [Full-text]
127. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.
     J Clin Invest, 115(4): 1030-8. [Abstract] [Full-text]
128. Adipokines: molecular links between obesity and atheroslcerosis.
     Am J Physiol Heart Circ Physiol, 288(5): H2031-41. [Abstract] [Full-text]
129. Impaired arachidonic acid-mediated dilation of small mesenteric arteries in Zucker diabetic fatty rats.
     Am J Physiol Heart Circ Physiol, 288(5): H2210-8. [Abstract] [Full-text]
130. Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats.
     Am J Physiol Heart Circ Physiol, 288(5): H2102-10. [Abstract] [Full-text]
131. Transoral obesity surgery: endoluminal gastroplasty with an endoscopic suture device.
     Endoscopy, 37(5): 411-4. [Abstract] [Full-text]
132. Maternal obesity and complications during pregnancy.
     J Perinat Med, 33(2): 100-5. [Abstract] [Full-text]
133. Butyrylcholinesterase activity and metabolic syndrome in obese patients.
     Clin Chem Lab Med, 43(3): 285-8. [Abstract] [Full-text]
134. A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin.
     Diabet Med, 22(5): 612-8. [Abstract] [Full-text]
135. Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
136. Psychological interventions for overweight or obesity.
     Cochrane Database Syst Rev. [Abstract] [Full-text]
137. Chronic treatment with exendin(9-39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice.
     J Endocrinol, 185(2): 307-17. [Abstract] [Full-text]
138. Does pretransplant obesity affect the outcome in kidney transplant recipients?
     Transplant Proc, 37(2): 717-20. [Abstract] [Full-text]
139. Income inequality and weight status in US metropolitan areas.
     Soc Sci Med, 61(1): 83-96. [Abstract] [Full-text]
140. Association of the apolipoprotein A-IV: 360 Gln/His polymorphism with cerebrovascular disease, obesity, and depression in a Brazilian elderly population.
     Am J Med Genet B Neuropsychiatr Genet, 135(1): 65-8. [Abstract] [Full-text]
141. Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population.
     BMC Med Genet, 6: 11. [Abstract] [Full-text]
142. The association of obesity, cytokine levels, and depressive symptoms with diverse measures of fatigue in healthy subjects.
     Arch Intern Med, 165(8): 910-5. [Abstract] [Full-text]
143. Monitoring trends in obesity in South Wales using routine data.
     Arch Dis Child, 90(5): 464-7. [Abstract] [Full-text]
144. Ingested cocoa can prevent high-fat diet-induced obesity by regulating the expression of genes for fatty acid metabolism.
     Nutrition, 21(5): 594-601. [Abstract] [Full-text]
145. Examining the relationships among built environment, physical activity, and body mass index in El Paso, TX.
     Prev Med, 40(6): 831-41. [Abstract] [Full-text]
146. Long-term maintenance of exercise and healthy eating behaviors in overweight adults.
     Prev Med, 40(6): 769-78. [Abstract] [Full-text]
147. Determinants of adolescent bicycle use for transportation and snacking behavior.
     Prev Med, 40(6): 658-67. [Abstract] [Full-text]
148. Health status, health behaviors, and acculturation factors associated with overweight and obesity in Latinos from a community and agricultural labor camp survey.
     Prev Med, 40(6): 642-51. [Abstract] [Full-text]
149. Dosage of enoxaparin among obese and renal impairment patients.
     Thromb Res, 116(1): 41-50. [Abstract] [Full-text]
150. Molecular and anatomical determinants of central leptin resistance.
     Nat Neurosci, 8(5): 566-70. [Abstract] [Full-text]
151. The hardship of obesity: a soft-wired hypothalamus.
     Nat Neurosci, 8(5): 561-5. [Abstract] [Full-text]
152. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children.
     Clin Endocrinol (Oxf), 62(5): 607-10. [Abstract] [Full-text]
153. Adiponectin, acylation stimulating protein and complement C3 are altered in obesity in very young children.
     Clin Endocrinol (Oxf), 62(5): 567-72. [Abstract] [Full-text]
154. Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance.
     Proc Natl Acad Sci U S A, 102(17): 6207-12. [Abstract] [Full-text]
155. Differential expression of dopamine D2 and D4 receptor and tyrosine hydroxylase mRNA in mice prone, or resistant, to chronic high-fat diet-induced obesity.
     Brain Res Mol Brain Res, 135(1): 150-61. [Abstract] [Full-text]
156. Stature and adiposity among children in contrasting neighborhoods in the city of Hamilton, Ontario, Canada.
     Am J Hum Biol, 17(3): 355-67. [Abstract] [Full-text]
157. Does physical activity modify the association between body mass index and colorectal adenomas?
     Nutr Cancer, 51(2): 140-5. [Abstract] [Full-text]
158. Is there an independent association between waist-to-hip ratio and cardiovascular risk factors in overweight and obese women?
     Int J Cardiol, 101(1): 39-46. [Abstract] [Full-text]
159. Ghrelin in growth and development.
     Horm Res, 63(3): 129-38. [Abstract] [Full-text]

© 2004-2008 Obesity Research Today. All Rights Reserved.